IMP
Process View
regulation of high density lipoprotein particle clearance
Any process that modulates the rate, frequency or extent of high-density lipoprotein particle clearance. High-density lipoprotein particle clearance is the process in which a high-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of high density lipoprotein particle clearance"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| APOA1 | apolipoprotein A-I | 1.000 | ||
| RPL18A | ribosomal protein L18a | 1.000 | ||
| ALB | albumin | 0.998 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.725 | ||
| FGA | fibrinogen alpha chain | 0.492 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.348 | ||
| APOA2 | apolipoprotein A-II | 0.333 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.287 | ||
| RIBC2 | RIB43A domain with coiled-coils 2 | 0.243 | ||
| HP | haptoglobin | 0.183 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.113 | ||
| PLA2G1B | phospholipase A2, group IB (pancreas) | 0.101 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.092 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.088 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.082 | ||
| PAH | phenylalanine hydroxylase | 0.073 | ||
| KIAA1377 | KIAA1377 | 0.071 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.065 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.064 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.060 | ||
| APOA4 | apolipoprotein A-IV | 0.057 | ||
| APOC1 | apolipoprotein C-I | 0.056 | ||
| OTC | ornithine carbamoyltransferase | 0.055 | ||
| UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.051 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.051 | ||
| PON1 | paraoxonase 1 | 0.051 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.050 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.049 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.049 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.049 | ||
| C4BPB | complement component 4 binding protein, beta | 0.046 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.045 | ||
| KNG1 | kininogen 1 | 0.045 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.040 | ||
| LECT2 | leukocyte cell-derived chemotaxin 2 | 0.039 | ||
| FGG | fibrinogen gamma chain | 0.039 | ||
| PLG | plasminogen | 0.039 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.036 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.035 | ||
| APOC2 | apolipoprotein C-II | 0.034 | ||
| CRP | C-reactive protein, pentraxin-related | 0.034 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.033 | ||
| F11 | coagulation factor XI | 0.033 | ||
| ORM2 | orosomucoid 2 | 0.032 | ||
| APOC4 | apolipoprotein C-IV | 0.032 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.031 | ||
| HPX | hemopexin | 0.030 | ||
| HAL | histidine ammonia-lyase | 0.030 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.030 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.030 | ||
| RPL36 | ribosomal protein L36 | 0.030 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.029 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.028 | ||
| REG1A | regenerating islet-derived 1 alpha | 0.028 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.027 | ||
| ORM1 | orosomucoid 1 | 0.027 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.026 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.024 | ||
| TREH | trehalase (brush-border membrane glycoprotein) | 0.024 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.023 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.023 | ||
| APCS | amyloid P component, serum | 0.022 | ||
| DCT | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) | 0.022 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.022 | ||
| SAA4 | serum amyloid A4, constitutive | 0.022 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.022 | ||
| GYS2 | glycogen synthase 2 (liver) | 0.022 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.021 | ||
| DDX56 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 | 0.021 | ||
| ZG16 | zymogen granule protein 16 homolog (rat) | 0.021 | ||
| HABP2 | hyaluronan binding protein 2 | 0.020 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.020 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.020 | ||
| AFM | afamin | 0.019 | ||
| GLYAT | glycine-N-acyltransferase | 0.018 | ||
| AES | amino-terminal enhancer of split | 0.018 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.018 | ||
| ELANE | elastase, neutrophil expressed | 0.018 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.017 | ||
| FGL1 | fibrinogen-like 1 | 0.017 | ||
| TF | transferrin | 0.017 | ||
| LBP | lipopolysaccharide binding protein | 0.017 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.016 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.016 | ||
| PNLIP | pancreatic lipase | 0.016 | Human | |
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.016 | ||
| CTRC | chymotrypsin C (caldecrin) | 0.016 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.016 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.015 | ||
| CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 | 0.015 | ||
| PNLIPRP1 | pancreatic lipase-related protein 1 | 0.015 | Human | |
| C9 | complement component 9 | 0.015 | ||
| F2 | coagulation factor II (thrombin) | 0.015 | ||
| TDO2 | tryptophan 2,3-dioxygenase | 0.014 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.014 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.014 | ||
| DPYS | dihydropyrimidinase | 0.014 | ||
| ADHFE1 | alcohol dehydrogenase, iron containing, 1 | 0.014 | ||
| FGB | fibrinogen beta chain | 0.014 | ||
| AFP | alpha-fetoprotein | 0.013 | ||
| CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 | 0.013 | ||
| GUCA2B | guanylate cyclase activator 2B (uroguanylin) | 0.013 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.013 | ||
| ARG1 | arginase, liver | 0.013 | ||
| RPS14 | ribosomal protein S14 | 0.013 | ||
| RPL8 | ribosomal protein L8 | 0.013 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.013 | ||
| CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 | 0.013 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.013 | ||
| HRG | histidine-rich glycoprotein | 0.012 | ||
| NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.012 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.012 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.012 | ||
| CA3 | carbonic anhydrase III, muscle specific | 0.012 | ||
| C8G | complement component 8, gamma polypeptide | 0.012 | ||
| REG3A | regenerating islet-derived 3 alpha | 0.012 | ||
| INHBA | inhibin, beta A | 0.012 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.012 | ||
| TMSB4Y | thymosin beta 4, Y-linked | 0.012 | ||
| GC | group-specific component (vitamin D binding protein) | 0.012 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.012 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.011 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.011 | ||
| F9 | coagulation factor IX | 0.011 | ||
| PRSS2 | protease, serine, 2 (trypsin 2) | 0.011 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.011 | ||
| KRT16 | keratin 16 | 0.011 | ||
| LPA | lipoprotein, Lp(a) | 0.011 | ||
| PRLR | prolactin receptor | 0.011 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.011 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.011 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | 0.011 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.010 | ||
| APOF | apolipoprotein F | 0.010 | ||
| ALAS2 | aminolevulinate, delta-, synthase 2 | 0.010 | ||
| SERPINA7 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 | 0.010 | ||
| TTR | transthyretin | 0.010 | ||
| HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B | 0.010 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.010 |